Search
In a community-based birth cohort of 158 Australian infants followed to age 2 years, the incidence rate of human parainfluenza virus (HPIV) was 0.42 (95% CI = 0.33, 0.54) episodes per child-year with episodes occurring year-round, peaking in the spring season.
The findings of this postmarketing assessment of the safety of 2 new enhanced influenza vaccines support confidence in ongoing vaccine use
Active vaccine safety surveillance leading to rapid detection of a safety signal would likely have resulted in earlier suspension of Fluvax from the vaccination programme
This report summarises the epidemiology of hospitalisations with laboratory-confirmed influenza during the 2017 influenza season
Improving parents’ and providers’ knowledge and confidence in influenza vaccination safety, efficacy, and benefits should be prioritised
Overall, the 2016 influenza vaccine showed good protection against laboratory-confirmed infection among general practice patients
This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of chronic lung diseases
Influenza infection in young children has a significant impact on medication use, absenteeism and the use of health care service
These baseline data are essential to assess the safety and effectiveness of influenza and pertussis vaccinations in pregnant women from the NT
AusVaxSafety surveillance demonstrated comparable and expected safety outcomes for the 2017 quadrivalent inactivated influenza vaccine brands used in Australia